Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ferraù

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Tumori|February 25, 2003
[4th National Conference of Medical Oncology. Evolution of the technology and clinical objectives of antitumor therapy]Salvatore Siena, Francesco Ferraù
European Journal of Endocrinology|June 11, 2015
Metabolic comorbidities in Cushing's syndromeFrancesco Ferraù, Márta Korbonits
Frontiers of Hormone Research|June 13, 2018
Metabolic Syndrome in Cushing's Syndrome PatientsFrancesco Ferraù, Márta Korbonits
Recenti Progressi in Medicina|November 18, 2020
[Genomic profiling and personalized approach, utopia or future reality? A clinical case.]Giovanna Antonelli, Francesco Ferraù
Critical Reviews in Oncology/Hematology|October 18, 2003
Fatigue and agingPaolo Tralongo, Daniela Respini, Francesco Ferraù
Pituitary|May 13, 2026
Recent progress in the understanding of psychological complications of acromegaly: toward a longitudinal clinical phenotypeGabriella Martino, Orlando Silvestro, Francesco Ferraù, et al.
Journal of Medical Case Reports|November 11, 2021
Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case reportGiuseppe Giuffrida, Francesco Ferraù, Ylenia Alessi, et al.
Journal of Drugs in Dermatology : JDD|June 9, 2016
Vitiligo of the Face in a Patient Treated With Vemurafenib for Metastatic MelanomaMaria Rita Nasca, Francesco Lacarrubba, Francesco Ferraù, et al.
Expert Opinion on Drug Safety|December 14, 2011
Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agentsVittorio Gebbia, Giuseppe Bellavia, Francesco Ferraù, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 18, 2019
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapySoraya Puglisi, Federica Spagnolo, Marta Ragonese, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Tumori|February 25, 2003
[4th National Conference of Medical Oncology. Evolution of the technology and clinical objectives of antitumor therapy]Salvatore Siena, Francesco Ferraù
European Journal of Endocrinology|June 11, 2015
Metabolic comorbidities in Cushing's syndromeFrancesco Ferraù, Márta Korbonits
Frontiers of Hormone Research|June 13, 2018
Metabolic Syndrome in Cushing's Syndrome PatientsFrancesco Ferraù, Márta Korbonits
Recenti Progressi in Medicina|November 18, 2020
[Genomic profiling and personalized approach, utopia or future reality? A clinical case.]Giovanna Antonelli, Francesco Ferraù
Critical Reviews in Oncology/Hematology|October 18, 2003
Fatigue and agingPaolo Tralongo, Daniela Respini, Francesco Ferraù
Pituitary|May 13, 2026
Recent progress in the understanding of psychological complications of acromegaly: toward a longitudinal clinical phenotypeGabriella Martino, Orlando Silvestro, Francesco Ferraù, et al.
Journal of Medical Case Reports|November 11, 2021
Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case reportGiuseppe Giuffrida, Francesco Ferraù, Ylenia Alessi, et al.
Journal of Drugs in Dermatology : JDD|June 9, 2016
Vitiligo of the Face in a Patient Treated With Vemurafenib for Metastatic MelanomaMaria Rita Nasca, Francesco Lacarrubba, Francesco Ferraù, et al.
Expert Opinion on Drug Safety|December 14, 2011
Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agentsVittorio Gebbia, Giuseppe Bellavia, Francesco Ferraù, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 18, 2019
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapySoraya Puglisi, Federica Spagnolo, Marta Ragonese, et al.
Pageof 13